SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-22-003516
Filing Date
2022-05-12
Accepted
2022-05-12 16:51:19
Documents
51
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q phio_i10q-033122.htm   iXBRL 10-Q 521956
2 CERTIFICATION phio_ex3101.htm EX-31.1 7460
3 CERTIFICATION phio_ex3201.htm EX-32.1 3720
  Complete submission text file 0001683168-22-003516.txt   3064214

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE phio-20220331.xsd EX-101.SCH 25114
5 XBRL CALCULATION FILE phio-20220331_cal.xml EX-101.CAL 35094
6 XBRL DEFINITION FILE phio-20220331_def.xml EX-101.DEF 91648
7 XBRL LABEL FILE phio-20220331_lab.xml EX-101.LAB 215543
8 XBRL PRESENTATION FILE phio-20220331_pre.xml EX-101.PRE 173842
45 EXTRACTED XBRL INSTANCE DOCUMENT phio_i10q-033122_htm.xml XML 444908
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36304 | Film No.: 22918648
SIC: 2834 Pharmaceutical Preparations